Evaluation of the roles as the biomarker of the nitric oxide in Japanese patients with respiratory diseases

Evaluation of the roles as the biomarker of the nitric oxide in Japanese patients with respiratory diseases - The role of NO in respiratory diseases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019433

Enrollment

150

Registered

2015-10-26

Start date

2015-10-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient with respiratory disease (interstitial pneumonia, lung cancer, respiratory infection, bronchial asthma, chronic obstructive pulmonary disease)

Exclusion criteria

Exclusion criteria: Less than 20 years old The patient who are already treated with the respiratory disease The patient who are treated with hypertension, chronic heart failure, diabetes, and/or hyperlipidemia The patients with are already administerd of steroid, immunosuppressive drug, and/or antibiotics The patient with serious liver dysfunction and/or renal dysfunction The patient who judged to be inappropriate for the study by attending physician

Design outcomes

Primary

Measure	Time frame
Comparison of the NOx level in every respiratory diseases	—

Secondary

Measure	Time frame
Comparison between the NOx level and the fibrotic severity of interstitial pneumonia Comparison between the NOx level and the staging of lung cancer	—

Countries

Japan

Contacts

Public ContactShingo Noguchi

University of Occupational and Environmental Health, Japan Department of Respiratory Medicine

k2684@med.uoeh-u.ac.jp+81-93-691-7453

Outcome results